trial

Association of Amisulpride Response in Schizophrenia With Brain Image

NCTId NCT02095938
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Unknown
Enrollment 20 (actual)
Sponsored by CHA University
Primary completion 2015-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Unknown
Enrollment
20 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2014-01
Primary completion
2015-12
Eligibility
ALL · 21 Years · 60 Years

Interventions & indications

Drugs
Amisulpride

Sponsors

CHA UniversityLead Sponsor
Handok Inc.Collaborator

Investigators

1
Sang-Hyuk Lee, MD., PhD.Principal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
20
Phase
PHASE4
Primary Completion Date
2015-12
Status
UNKNOWN
relationships
The graph out of here
drug
Amisulpride
drug
lead_sponsor
CHA University
company
collaborator
Handok Inc.
company
indication
Schizophrenia
indication
Schizophreniform Disorder
indication
Schizophrenia
indication
investigator
Sang-Hyuk Lee, MD., PhD.
person